Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H33NO2 |
Molecular Weight | 355.5136 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])CC=C4C(C)(C)C5=C(C[C@]34C)C=NO5
InChI
InChIKey=AXLOCHLTNQDFFS-BESJYZOMSA-N
InChI=1S/C23H33NO2/c1-20(2)18-7-6-15-16(21(18,3)12-14-13-24-26-19(14)20)8-10-22(4)17(15)9-11-23(22,5)25/h7,13,15-17,25H,6,8-12H2,1-5H3/t15-,16+,17+,21-,22+,23+/m1/s1
Molecular Formula | C23H33NO2 |
Molecular Weight | 355.5136 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
AZASTENE is an inhibitor of ovarian and adrenal steroidogenesis which can be used as an interceptive agent. Its action leads to an acute, short-term, reversible progesterone withdrawal. The reduction of progesterone levels is brought about by competitive inhibition of ovarian 3beta-hydroxysteroid dehydrogenase activity.
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6574022
The 3beta-hydroxysteroid dehydrogenase and 20alpha-hydroxysteroid dehydrogenase from human placenta preparation were inhibited by azastene (IC50 1 microM and 0.6 microM, respectively).
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:20:05 GMT 2023
by
admin
on
Fri Dec 15 15:20:05 GMT 2023
|
Record UNII |
1XA84ITL1H
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C389
Created by
admin on Fri Dec 15 15:20:05 GMT 2023 , Edited by admin on Fri Dec 15 15:20:05 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID801180403
Created by
admin on Fri Dec 15 15:20:05 GMT 2023 , Edited by admin on Fri Dec 15 15:20:05 GMT 2023
|
PRIMARY | |||
|
4331
Created by
admin on Fri Dec 15 15:20:05 GMT 2023 , Edited by admin on Fri Dec 15 15:20:05 GMT 2023
|
PRIMARY | |||
|
C017039
Created by
admin on Fri Dec 15 15:20:05 GMT 2023 , Edited by admin on Fri Dec 15 15:20:05 GMT 2023
|
PRIMARY | |||
|
1XA84ITL1H
Created by
admin on Fri Dec 15 15:20:05 GMT 2023 , Edited by admin on Fri Dec 15 15:20:05 GMT 2023
|
PRIMARY | |||
|
11725766
Created by
admin on Fri Dec 15 15:20:05 GMT 2023 , Edited by admin on Fri Dec 15 15:20:05 GMT 2023
|
PRIMARY | |||
|
Azastene
Created by
admin on Fri Dec 15 15:20:05 GMT 2023 , Edited by admin on Fri Dec 15 15:20:05 GMT 2023
|
PRIMARY | |||
|
SUB05644MIG
Created by
admin on Fri Dec 15 15:20:05 GMT 2023 , Edited by admin on Fri Dec 15 15:20:05 GMT 2023
|
PRIMARY | |||
|
C77443
Created by
admin on Fri Dec 15 15:20:05 GMT 2023 , Edited by admin on Fri Dec 15 15:20:05 GMT 2023
|
PRIMARY | |||
|
CHEMBL2103987
Created by
admin on Fri Dec 15 15:20:05 GMT 2023 , Edited by admin on Fri Dec 15 15:20:05 GMT 2023
|
PRIMARY | |||
|
100000086079
Created by
admin on Fri Dec 15 15:20:05 GMT 2023 , Edited by admin on Fri Dec 15 15:20:05 GMT 2023
|
PRIMARY | |||
|
13074-00-5
Created by
admin on Fri Dec 15 15:20:05 GMT 2023 , Edited by admin on Fri Dec 15 15:20:05 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |